- I'm not really surprised about Zacks - but like Prez Reagan would say - trust but verify. So I went over to Zacks, and saw:
"Consensus Estimate for Next Fiscal Year ( 12/99 ) $ 3.49 per share"
- There's even one analyst with a "Strong Buy" - that the highest rating.
- Plus, analysts are estimating a loss of 4 cents for this quarter. And with all of the advertising and new plant costs, who knows, Vivus may really post a loss. But then again, if approval received this month or early FEb, and all that product gets snatched up by Astra and sold in Europe & beyone, and who knows?
- Bottom line: I'm not surprsed by the $3.49 earnings projection. In fact, after the Dec '97 confer call, several posters, including myself, said Vivus could do $3 or $4 a share. VVUS stock was at $10. And folks said it was crazy. As we get closer to new plant approval, it's seeming more achievable.
Out. |
